You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
|
---|---|
Published in |
Frontiers in Pharmacology, January 2019
|
DOI | 10.3389/fphar.2018.01521 |
Pubmed ID | |
Authors |
Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren, Matitiahu Berkovitch |
X Demographics
The data shown below were collected from the profiles of 197 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 30 | 15% |
Japan | 14 | 7% |
United Kingdom | 6 | 3% |
Spain | 5 | 3% |
Canada | 4 | 2% |
Colombia | 3 | 2% |
Netherlands | 2 | 1% |
Chile | 2 | 1% |
Australia | 2 | 1% |
Other | 18 | 9% |
Unknown | 111 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 169 | 86% |
Practitioners (doctors, other healthcare professionals) | 20 | 10% |
Scientists | 8 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 396 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 396 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 50 | 13% |
Student > Master | 38 | 10% |
Researcher | 31 | 8% |
Student > Ph. D. Student | 30 | 8% |
Student > Doctoral Student | 24 | 6% |
Other | 71 | 18% |
Unknown | 152 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 15% |
Psychology | 29 | 7% |
Neuroscience | 24 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 5% |
Biochemistry, Genetics and Molecular Biology | 19 | 5% |
Other | 75 | 19% |
Unknown | 171 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 281. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2023.
All research outputs
#128,564
of 25,711,194 outputs
Outputs from Frontiers in Pharmacology
#49
of 19,994 outputs
Outputs of similar age
#2,588
of 449,089 outputs
Outputs of similar age from Frontiers in Pharmacology
#1
of 334 outputs
Altmetric has tracked 25,711,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,994 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 334 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.